78
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator-and apolipoprotein E-conjugated liposomes to the hippocampus

&
Pages 6809-6824 | Published online: 15 Dec 2016

References

  • GoedertMSpillantiniMGA century of Alzheimer’s diseaseScience200631477778117082447
  • Alzheimer’s Association2016 Alzheimer’s disease facts and figuresAlzheimers Dement20161217926710324
  • ObaraYYamauchiATakeharaSNiemotoWTakahashiMStorkPJERK5 activity is required for nerve growth factor-induced neurite outgrowth and stabilization of tyrosine hydroxylase in PC12 cellsJ Biol Chem20092846473
  • SofroniewMVHoweCLMobleyWCNerve growth factor signaling, neuroprotection, and neural repairAnnu Rev Neurosci2001241217128111520933
  • BottgerDUllrichCHumpelCMonocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neuronsBrain Res2010131210811920004179
  • Eriksdotter-JonhagenMNordbergAAmberlaKIntracerebroventricular infusion of nerve growth factor in three patients with Alzheimer’s diseaseDement Geriatr Cogn Disord199892462579701676
  • SaltTEHillRGNeurotransmitter candidates of somatosensory primary afferent fibresNeuroscience198310108311036198599
  • RouselleJCMassotODelepierreMZifaERosseauBFillionGIsolation and characterization of an endogenous peptide from rat brain interacting specifically with the serotonergic 1B receptor subtypesJ Biol Chem19962717267358557679
  • UllmerCSchmuckKKalkmanHLubbertHExpression of serotonin receptor mRNAs in blood vesselsFEBS Lett19953702152217656980
  • ReFCambianicaISesanaSFunctionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptideJ Biotechnol201115634134621763360
  • WagnerSZensiAWienSLUptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood–brain barrier modelPLoS One20127e3256822396775
  • MahleyRWApolipoprotein E: cholesterol transport protein with expanding role in cell biologyScience19882406226303283935
  • LaDuMJGilliganSMLukensJRNascent astrocyte particles differ from lipoproteins in CSFJ Neurochem199870207020819572293
  • LaDuMJShahJAReardonCAApolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responsesNeurochem Int20013942743411578778
  • KuoYCSuFLTransport of stavudine, delavirdine, and saquinavir across the blood–brain barrier by polybutylcyanoacrylate, methylmethacrylate–sulfopropylmethacrylate, and solid lipid nanoparticlesInt J Pharm200734014315217418986
  • KuoYCLuCHEffect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood–brain barrierColloids Surf B Biointerfaces20118622523121524890
  • KuoYCWangCTProtection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrinBiomaterials2014355954596424746790
  • KlingenbergMCardiolipin and mitochondrial carriersBiochim Biophys Acta200917882048205819539604
  • YousefiAEsmaeiliFRahimianSAtyabiFDinarvandRPreparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxelScientia Pharmaceutica200977453464
  • KuoYCChouPRNeuroprotection against degeneration of SK-N-MC cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrinJ Pharm Sci20141032484249725041794
  • NiiTIshiiFEncapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle methodInt J Pharm200529819820515951143
  • XieYYeLZhangXTransport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: in vitro and in vivo studiesJ Control Release200510510611915893839
  • ShimojiMImaizumiNAniyaYModulation of membrane-bound glutathione transferase activity by phospholipids including cardiolipinBiol Pharm Bull20113420921321415529
  • MullerRHMaassenSWeyhersHSpechtFLucksJSCytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticlesInt J Pharm19961388594
  • KuoYCWangCCCationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endotheliaColloids Surf B Biointerfaces201310110110522796778
  • JonesCFGraingerDWIn vitro assessments of nanomaterial toxicityAdv Drug Deliv Rev20096143845619383522
  • LinCHAl-SuwayehSAHungCFChenCCFangJYCamptothecin-loaded liposomes with α-melanocyte-stimulating hormone enhance cytotoxicity toward and cellular uptake by melanomas: an application of nanomedicine on natural productJ Tradit Complemen Med20133102109
  • KuoYCChungJFPhysicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriersColloids Surf B Biointerfaces20118329930621194902
  • DejanaEEndothelial cell-cell junctions: happy togetherNat Rev Mol Cell Biol2004526127015071551
  • KuoYCKuoCYElectromagnetic interference in the permeability of saquinavir across the blood–brain barrier using nanoparticulate carriersInt J Pharm200835127128117976933
  • KaiserMPereiraSPohlLChitosan encapsulation modulates the effect of capsaicin on the tight junctions of MDCK cellsSci Rep201551004825970096
  • PardridgeWMDrug targeting to the brainPharm Res2007241733174417554607
  • HeftiFIs Alzheimer disease caused by lack of nerve growth factor?Ann Neurol1983131091106830157
  • LongoFMVuTKMobleyWCThe in vitro biological effect of nerve growth factor is inhibited by synthetic peptidesCell Regulation199011891952100197
  • FridenPMWalusLRWatsonPBlood–brain barrier penetration and in vivo activity of an NGF conjugateScience19932593733778420006
  • YingXWenHLuaWLDual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animalsJ Control Release201014118319219799948
  • DuzgunesNNirSMechanisms and kinetics of liposome-cell interactionsAdv Drug Deliv Rev19994031810837777
  • DehouckBFenartLDehouckMPPierceATorpierGCecchelliRA new function for the LDL receptor: transcytosis of LDL across the blood–brain barrierJ Cell Biol19971388778899265653
  • ElshourbagyNALiaoWSMahleyRWTaylorJMApolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosetsProc Natl Acad Sci U S A1985822032073918303
  • RiadMTongXKMestikawySEHamonMHamelEDescarriesLEndothelial expression of the 5-hydoroxytriptamine1B antimigraine drug receptor in rat and human brain vesselsNeuroscience199886103110359697110
  • GobbiMReFCanoviMLipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptideBiomaterials2010316519652920553982
  • ShaykhalishahiHTaghizadehMYazdanparastRChangYTAnti-amyloidogenic effect of AA3E2 attenuates beta-amyloid induced toxicity in SK-N-MC cellsChem Biol Interact2010186162320359466
  • ShibataAIkawaKShimookaTTeradaHSignificant stabilization of the phosphatidylcholine bilayer structure by incorporation of small amounts of cardiolipinBiochim Biophys Acta1994119271788204653
  • BulbarelliALonatiECazzanigaETrkA pathway activation induced by amyloid-beta (Abeta)Mol Cell Neurosci20094036537319162192
  • NiewiadomskaGMietelska-PorowskaAMazurkiewiczMThe cholinergic system, nerve growth factor and the cytoskeletonBehav Brain Res201122151552620170684
  • BuGApolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapyNat Rev Neurosci20091033334419339974
  • HirstWDSteanTORogersDCSB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition modelsEur J Pharmacol200655310911917069795
  • KuoYCLinCYTargeting delivery of liposomes with conjugated p-aminophenyl-α-D-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptideJ Drug Target20152314715825268274
  • Negre-SalvayreACoatrieuxCIngueneauCSalvayreRAdvanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitorsBrit J Pharmacol200815362017643134
  • LovellMEhmannWButlerSMarkesberyWElevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s diseaseNeurology199545159416017644059
  • PraticoDUryuKLeightSTrojanoswkiJQLeeVMIncreased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosisNeuroscience2001214183418711404403
  • Garcia-AyllonMSSilveyraMXSaez-ValeroJAssociation between acetylcholinesterase and beta-amyloid peptide in Alzheimer’s cerebrospinal fluidChem Biol Interact200817520921518554581
  • MeloJBAgostinhoPOliveiraCRInvolvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptideNeurosci Res20034511712712507730
  • Bentue-FerrerDReymannJMRousselleJC5-HT-moduline, a 5-HT1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysisEur J Pharmacol19983581291379808261
  • MauchDHNaglerKSchumacherSCNS synaptogenesis promoted by glia-derived cholesterolScience20012941354135711701931
  • CharlesVMufsonEJFridenPMBartusRTKordowerJHAtrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugateBrain Res19967281932038864482